Compare FDC LTD. with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. AJANTA PHARMA FDC LTD./
AJANTA PHARMA
 
P/E (TTM) x 23.5 31.5 74.5% View Chart
P/BV x 4.5 6.6 69.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 FDC LTD.   AJANTA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-18
AJANTA PHARMA
Mar-19
FDC LTD./
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3191,422 22.4%   
Low Rs164898 18.3%   
Sales per share (Unadj.) Rs61.6233.5 26.4%  
Earnings per share (Unadj.) Rs9.944.0 22.6%  
Cash flow per share (Unadj.) Rs12.052.2 22.9%  
Dividends per share (Unadj.) Rs09.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs73.2255.1 28.7%  
Shares outstanding (eoy) m174.4088.02 198.1%   
Bonus/Rights/Conversions BBBB-  
Price / Sales ratio x3.95.0 78.9%   
Avg P/E ratio x24.326.4 92.0%  
P/CF ratio (eoy) x20.222.2 90.8%  
Price / Book Value ratio x3.34.5 72.6%  
Dividend payout %020.5 0.0%   
Avg Mkt Cap Rs m42,118102,081 41.3%   
No. of employees `0005.56.8 81.3%   
Total wages/salary Rs m2,1674,307 50.3%   
Avg. sales/employee Rs Th1,943.73,022.6 64.3%   
Avg. wages/employee Rs Th391.7633.4 61.8%   
Avg. net profit/employee Rs Th313.7569.1 55.1%   
INCOME DATA
Net Sales Rs m10,75120,554 52.3%  
Other income Rs m510211 241.7%   
Total revenues Rs m11,26020,765 54.2%   
Gross profit Rs m2,2675,664 40.0%  
Depreciation Rs m351721 48.8%   
Interest Rs m1412 120.7%   
Profit before tax Rs m2,4115,143 46.9%   
Minority Interest Rs m-50-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6711,273 52.7%   
Profit after tax Rs m1,7353,870 44.8%  
Gross profit margin %21.127.6 76.5%  
Effective tax rate %27.824.8 112.5%   
Net profit margin %16.118.8 85.7%  
BALANCE SHEET DATA
Current assets Rs m7,21311,812 61.1%   
Current liabilities Rs m2,1043,776 55.7%   
Net working cap to sales %47.539.1 121.5%  
Current ratio x3.43.1 109.6%  
Inventory Days Days5477 70.4%  
Debtors Days Days2882 34.0%  
Net fixed assets Rs m6,86514,398 47.7%   
Share capital Rs m175175 99.9%   
"Free" reserves Rs m12,58622,277 56.5%   
Net worth Rs m12,76122,452 56.8%   
Long term debt Rs m67 90.9%   
Total assets Rs m15,04126,962 55.8%  
Interest coverage x173.2444.3 39.0%   
Debt to equity ratio x00 159.9%  
Sales to assets ratio x0.70.8 93.8%   
Return on assets %11.614.4 80.8%  
Return on equity %13.617.2 78.9%  
Return on capital %19.023.0 82.6%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,88910,682 17.7%   
Fx outflow Rs m02,102 0.0%   
Net fx Rs m1,8898,580 22.0%   
CASH FLOW
From Operations Rs m1,4983,748 40.0%  
From Investments Rs m201-2,228 -9.0%  
From Financial Activity Rs m-1,694-1,475 114.9%  
Net Cashflow Rs m1045 22.8%  

Share Holding

Indian Promoters % 68.9 73.8 93.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 1.6 303.2%  
FIIs % 7.5 7.6 98.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 17.0 111.8%  
Shareholders   23,730 20,968 113.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PIRAMAL ENTERPRISES  NOVARTIS  ALEMBIC PHARMA  DR. REDDYS LAB  GSK PHARMA  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 225 Points Higher; Metal and Banking Stocks Witness Buying(Closing)

Extending gains to the fourth consecutive session, Indian share markets witnessed buying interest throughout the day today and ended higher.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 11, 2020 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS